PRN: Global HLA Typing Transplant Market to Grow at a CAGR of 9.2% by 2021: Growth Driven by New Government Initiatives for HLA Typing - Research and Markets

04/mag/2017 11:30:11 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global HLA Typing Transplant Market to Grow at a CAGR of 9.2% by 2021: Growth Driven by New Government Initiatives for HLA Typing - Research and Markets

 
[04-May-2017]
 

DUBLIN, May 04, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global HLA Typing Transplant Market 2017-2021" report to their offering.

Research and Markets Logo

The global HLA typing transplant market to grow at a CAGR of 9.20% during the period 2017-2021.

The report, Global HLA Typing Transplant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is new government initiatives for HLA typing. The growing concerns about hepatitis and HIV are leading the government to develop few standards and strategies to reduce the number of communicable diseases through transplantation. Quality measurement in government-introduced programs lead to increased adoption of bone marrow and umbilical cord transplantation.

According to the report, one driver in the market is growing incidence of organ failure. The demand for tissue and organs such as bone marrow, heart, liver, kidney, and lungs is very high worldwide. The increasing rate of alcohol consumption, unhealthy lifestyles and food habits, and drug intake are the leading causes of organ failure. In addition, the rise in older adult population results in increased demand for organs for transplantation. According to a combined study conducted by the Department of Internal Medicine, Division of Hepatology, Loyola University Medical Center; Department of Preventive Health Sciences, Stritch School of Medicine, Loyola University Chicago; and Division of Gastroenterology and Hepatology, University of Michigan Health System, in 2015, liver cirrhosis is one of the major factors of death in the US.

Key vendors

  • Immucor
  • Illumina
  • Thermo Fisher Scientific

Other prominent vendors

  • Biofortuna
  • Bio-Rad Laboratories
  • Cellular Technology
  • GenDx
  • HistoGenetics
  • InGen
  • Linkage Biosciences
  • Omixon
  • Pacific Biosciences of California
  • STRATEC Biomedical

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by products

PART 07: Market segmentation by technology

PART 08: Market segmentation by end-user

PART 09: Geographical segmentation

PART 10: Decision framework

PART 11: Drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape

PART 14: Key vendor analysis

PART 15: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/4zmjxq/global_hla_typing

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl